Unusual trading in OTC stock sparks probe in British

New Post Public Reply Private Reply Replies (0) Message Board
MaxShockeR

Unusual trading in OTC stock sparks probe in British Columbia

7/20/2012 9:01:18 PM | Peter Kennedy

The BCSC recently halted trading in Vancouver-based Forum National Investments, which saw its stock price soar to over $2.50 from 15 cents earlier this year.

The executive director of the British Columbia Securities Commission has issued a temporary order and notice of hearing against three men and a B.C.-based company over concerns about unusual trading volume and share price increases.

The temporary order bars all trading or transferring of the shares of Forum National Investments Ltd. (OBB: FMNL, Stock Forum), a B.C. reporting issuer that is quoted on the U.S. OTC Bulletin Board and recently saw its share price skyrocket in the wake of a paid promotion campaign.

The executive director initially intervened by issuing a halt trade order on June 28, 2012. But he will aim to have the order extended at a hearing in Vancouver on July 31.

Daniel Clozza, Martin Tutschek and Grant Curtis, all of whom are B.C. residents, are named in the notice of hearing. Clozza is the President, CEO, and director of Forum National, while Tutschek is the chief financial officer and a company director. Curtis is a shareholder.

The notice says BCSC staff is concerned with the unusual trading volume and price increase in the shares of Forum National that occurred between May and June 2012. Staff is also concerned with the apparent attempts to violate or circumvent the halt trade order by transferring or issuing shares of Forum National.

During the relevant period, the market for Forum National shares experienced a sudden increase in trading volume and price. In fact, the market capitalization of Forum National increased from just over US$6 million to over US$120 million.

On April 11, 2012 Forum closed at 15 cents on volume of 110,000, leaving the company with a market cap of $6.4 million, based on 42.4 million shares outstanding.

During May and June, Forum National shares experienced a sudden increase in trading volume and price that coincided with certain news releases and an internet promotion campaign.

On July 18, 2012, Forum National shares closed at US$2.80, raising the market cap to US$120.8 million, based on 43.1 million shares outstanding.

During this sudden increase, Forum National was the subject of an internet promotion campaign funded by undisclosed persons, and the company itself issued seven news releases related to the expansion of its viatical settlement business.

Viatical settlement

According to the BCSC, some of the internet stock promotion websites explicitly stated that over US$650,000 had been spent to promote Forum National. “The internet material was highly promotional and predicted a significant increase in the shares of Forum National, generally projecting a target price of US$10,’’ the BCSC said in the notice of hearing released on Friday.

A viatical settlement is a term used for a settlement involving an insured person who is terminally or chronically ill. It involves the sale of a policy owner’s existing life insurance policy to a third party for more than its cash surrender value, but less than its net death benefit.

Such a sale provides the owner with a lump sum. The third party becomes the new owner of the policy, pays the monthly premiums and receives the full benefit of the policy when the insured dies. According to Wikipedia, purchasing a viatical is similar to buying a zero coupon bond with an uncertain maturity date. The return depends on the seller’s life expectancy and when he or she dies.

The BCSC said the news releases allegedly indicate that between May 15, 2012 and June 25, 2012, Forum National had taken significant steps to expand its viatical insurance settlement business. However, the BCSC says these claims cannot currently be independently verified with publicly available information.

Significant trading

BCSC staff requested that Forum National issue a clarifying news release explaining what role, if any, the company or any of its management had in the promotional internet campaign. To date, the company has declined to issue the release.

Meanwhile, accounts in the name of individuals associated with Clozza engaged significant trading, the BCSC is alleging:

Between April 20, 2012 and June 22, 2012, the account belonging to Clozza’s 74-year-old mother bought 98,600 shares and sold 314,600 shares, for gross profits of $121,697.

Between April 26, 2012 and June 28, 2012, Curtis’s account received a transfer of one million Forum National shares, bought an additional 54,275 shares and sold 735,625 shares for gross profits of $738, 041.

These two accounts are held at a branch of a Vancouver investment dealer, which had at least 52 separate accounts that held positions or traded in Forum National during the relevant period.

These allegations have not been proven. Counsel for the executive director will apply to extend the temporary halt trade order pending an investigation into:

1. The source and funding of the internet material.

2. A connection, if any, between the internet material and the respondents.

3. Reasons for the increased price and trading volume of Forum National shares

4. Attempts to circumvent or violate the halt trade order through transferring and issuing shares of Forum National.

5. Forum National has adequately disclosed the extent to which the company and each of its directors, officers and insiders are involved in or had any knowledge of the Internet material.

6. Forum National has provided the executive director with information that adequately supports the claims make in its news releases.

More allegations about unexplained attempts to transfer shares

The BCSC alleges that on July 5, 2012, Clozza and Tutschek attended the offices of Forum National’s transfer agent in Vancouver. They allegedly carried with them share certificates representing approximately 2.7 million shares of Forum National. Among these, were certificates in the names of Curtis and Tutschek, the Commission alleges.

Clozza allegedly instructed the transfer agent to “overnight” transfer share certificates into the name of a Bahamian company by way of a U.S. brokerage firm. The transfer agent allegedly informed the commission.

On July 16, 2012, Tutschek allegedly sent the transfer agent a treasury direction signed by Clozza and Tutschek on July 11, 2012, directing it to issue share certificates representing 137,500 shares in Forum National. The transfer agent refused.


ABOUT THE AUTHOR Peter Kennedy is a Stockhouse reporter and web content editor.

http://www.stockhouse.com/cmspages/handler404...e-in-briti


Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 221

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 79

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 189

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 85

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 129

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 389

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 0

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Master Sommeliers and Italian Producers Clash on Wine Lists

Updated Category News Views 166

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Continue Reading

Top 5 Most Recently Viewed Articles

Vor Bio's Exploration of Strategic Alternatives for Growth

Updated Category News Views 213

Vor Bio Announces Exploration of Strategic Alternatives Today, Vor Bio, a clinical-stage cell and genome engineering company, has taken significant steps to enhance shareholder value. The decision comes at a time when the clinical data from its major programs suggests that reevaluating its approach could be beneficial in the face of challenging fundraising conditions....

Continue Reading
Kraig Biocraft Achieves Record Production in Spider Silk Fibers

Updated Category News Views 56

Kraig Biocraft Laboratories' Milestone in Spider Silk Production Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB), a pioneering firm renowned for its innovative developments in spider silk-based fibers, is thrilled to share the successful conclusion of its fourth production cycle for the year. This cycle represents a remarkable achievement, showcasing record-breaking...

Continue Reading
Gen X Faces Retirement Challenges: Understanding the Crisis

Updated Category News Views 282

Gen X’s Coming Retirement Crunch Gen X—often called the “sandwich generation”—is being pulled in two directions at once and edging toward a retirement problem many don’t fully see. With money, time, and attention split between family and work, long-term savings can drift to the back burner. The worry isn’t abstract; it’s about whether the money will be...

Continue Reading
Luxurious Villa Spectre: A $55 Million Icon of Elegance

Updated Category News Views 342

Villa Spectre: A $55 Million Marvel of Luxury Living Villa Spectre has recently captured the spotlight as the highest-priced sale in the area, setting a remarkable benchmark in luxury real estate. This impressive estate was sold for $55,000,000, showcasing the allure and opulence that the elite have come to expect from high-end properties. A Visionary Creation Designed by...

Continue Reading
Mosaic Minerals Shifts Focus to Gold with Amanda Acquisition

Updated Category News Views 333

Mosaic Minerals Re-prioritizes Focus on Gold Exploration Mosaic Minerals Corporation (CSE: MOC) is making a strategic pivot in its exploration efforts. The company has announced the cessation of its lithium exploration initiatives, particularly those in Jamésie, Quebec. Instead, Mosaic is setting its sights on more promising ventures in gold and nickel, specifically...

Continue Reading